Evidence map›Paper›PMID 23219941›Full record

ArticleNeuroscience2013

Neural expression of the transcription factor THAP1 during development in rat.

Y Zhao, J Xiao, S Gong, J A Clara, M S Ledoux

Abstract read
In one paragraph

Article in Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. DYT6 Dystonia: A Neuropathological Study.Neuro-degenerative diseases · 2016
    Article
  12. Inherited isolated dystonia: clinical genetics and gene function.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2014
    Review
  13. Article
  14. Recent advances in the genetics of dystonia.Current neurology and neuroscience reports · 2014
    Review
  15. Article
  16. Emerging common molecular pathways for primary dystonia.Movement disorders : official journal of the Movement Disorder Society · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Y ZhaoDepartment of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
J Xiao
S Gong
J A Clara
M S Ledoux
University of Tennessee Health Science Center · US

Funding

The Role of THAP1 in DystoniaR01NS069936 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LEDOUX, MARK S · 2010 to 2013
$1.3M
NINDS NIH HHS R01 NS069936NINDS NIH HHS R01NS069936
6 · The paper itself

Abstract

Loss of function mutations in THAP1 has been associated with primary generalized and focal dystonia in children and adults. THAP1 encodes a transcription factor (THAP1) that harbors an atypical zinc finger domain and plays a critical role in G(1)-S cell cycle control. Current thinking suggests that dystonia may be a neurodevelopmental circuit disorder. Hence, THAP1 may participate in the development of the nervous system. Herein, we report the neurodevelopmental expression patterns of Thap1 transcript and THAP1 protein from the early postnatal period through adulthood in the rat brain, spinal cord and dorsal root ganglia (DRG). We detected Thap1 transcript and THAP1-immunoreactivity (IR) in the cerebral cortex, cerebellum, striatum, substantia nigra, thalamus, spinal cord and DRG. Thap1 transcript expression was higher in the brain than in spinal cord and DRG at P1 and P7 and declined to similar levels at P14 and later time points in all regions except the cerebellum, where it remained high through adulthood. In the brain, THAP1 expression was highest in early development, particularly in the cerebellum at P7. In addition to Purkinje cells in the cerebellum, THAP1-IR was also localized to pyramidal neurons in the cerebral cortex, relay neurons in the thalamus, medium spiny and cholinergic neurons in the striatum, dopaminergic neurons in the substantia nigra, and pyramidal and interneurons in the hippocampus. In the cerebellar cortex, THAP1-IR was prominently distributed in the perikarya and proximal dendrites of Purkinje cells at early time-points. In contrast, it was more diffusely distributed throughout the dendritic arbor of adult Purkinje cells producing a moderate diffuse staining pattern in the molecular layer. At all time points, nuclear IR was weaker than cytoplasmic IR. The prominent cytoplasmic and developmentally regulated expression of THAP1 suggests that THAP1 may function as part of a cell surface-nucleus signaling cascade involved in terminal neural differentiation.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsApoptosis Regulatory ProteinsBrainDNA-Binding ProteinsHEK293 CellsHumansMaleNerve Tissue ProteinsNeuronsNuclear ProteinsRatsRats, Sprague-DawleyTranscription FactorsApoptosis Regulatory ProteinsDNA-Binding ProteinsNerve Tissue ProteinsNuclear ProteinsTHAP1 protein, ratTranscription Factors

Identifiers

PMID23219941
PMCPMC3558550
OpenAlexW1969558551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.